Wei Jiang

Wei Jiang

Auto-generated profile, based on publicly available information

Wei Jiang

Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXianzhu Zhang
Xianzhu Zhang
WJWei Jiang
Wei Jiang
CXChang Xie
Chang Xie
XWXinyu Wu
Xinyu Wu
QRQian Ren
Qian Ren
HOHongwei Ouyang
Hongwei Ouyang
Critical-sized bone defects often lead to non-union and full-thickness defects of the calvarium specifically still present reconstructive challenges. In this study, we show that neurotrophic supplements induce robust in vitro expansion of mesenchymal stromal cells, and in situ transplantation of neurotrophic supplements-incorporated 3D-printed hydrogel grafts promote full-thickness regeneration of critical-sized bone defects. Single-cell RNA sequencing analysis reveals that a unique atlas of in situ stem/progenitor cells is generated during the calvarial bone healing in vivo. Notably, we find a local expansion of resident Msx1+ skeletal stem cells after transplantation of the in situ cell culture system. Moreover, the enhanced calvarial bone regeneration is accompanied by an increased endochondral ossification that closely correlates to the Msx1+ skeletal stem cells. Our findings illustrate the time-saving and regenerative efficacy of in situ cell culture systems targeting major cell subpopulations in vivo for rapid bone tissue regeneration.

27 September 2022 in Cell Discovery
Verified
Journal Article
Open access
PDF file
BWBingbing Wu
Bingbing Wu
YLYu Li
Yu Li
NNNanfang Nie
Nanfang Nie
XSXilin Shen
Xilin Shen
WJWei Jiang
Wei Jiang
XZXiaohui Zou
Xiaohui Zou
Our understanding of full-thickness endometrial regeneration after injury is limited by an incomplete molecular characterization of the cell populations responsible for the organ functions. To help fill this knowledge gap, we characterized 10,551 cells of full-thickness normal human uterine from two menstrual phases (proliferative and secretory phase) using unbiased single cell RNA-sequencing. We dissected cell heterogeneity of main cell types (epithelial, stromal, endothelial, and immune cells) of the full thickness uterine tissues, cell population architectures of human uterus cells across the menstrual cycle. We identified an SFRP4+ stromal cell subpopulation that was highly enriched in the regenerative stage of the human endometria during the menstrual cycle, and the SFRP4+ stromal cells could significantly enhance the proliferation of human endometrial epithelial organoid in vitro, and promote the regeneration of endometrial epithelial glands and full-thickness endometrial injury through IGF1 signaling pathway in vivo. Our cell atlas of full-thickness uterine tissues revealed the cellular heterogeneities, cell population architectures, and their cell–cell communications during the monthly regeneration of the human endometria, which provide insight into the biology of human endometrial regeneration and the development of regenerative medicine treatments against endometrial damage and intrauterine adhesion.

4 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXianzhu Zhang
Xianzhu Zhang
WJWei Jiang
Wei Jiang
XWXinyu Wu
Xinyu Wu
CXChang Xie
Chang Xie
YZYi Zhang
Yi Zhang
HOHongwei Ouyang
Hongwei Ouyang
Current approaches for bone repair predominantly target localized delivery of growth factors that are aimed at the coupling of angiogenesis and osteogenesis. However, delayed revascularization and regeneration of critical-sized bone defects are still challenging. In this study, we engineer an ossification center-like organoid (OCO) that consist of an inner-core bone morphogenetic and neurotrophic spheroid generated via MSCs-loaded 3D printing, alongside the interstitially distributed outer-shell proangiogenic neurotrophic phase. Our results demonstrate that collective implantation of OCOs achieves rapid bone bridging with successive OC-like bone ossicles formation across the bone defect in a “divide-and-conquer” way. Single-cell RNA sequencing analysis unveils a developmentally mimicking stem cell community that dominated with Krt8+ skeletal stem cells (SSCs) is uniquely recruited by the pro-regenerative in-situ organoid fusion and maturation. Particularly noteworthy is the specific expansion of Krt8+ SSCs concomitant with the simultaneous reduction of Has1+ migratory fibroblasts (MFs) post-OCO implantation. Furthermore, cross-species comparisons employing machine learning reveal high resemblance of the relative Krt8+ SSCs/Has1+ MFs composition in bone regeneration with that in public data from developmental bone tissues. Our findings advocate an approach akin to “divide-and-conquer” utilizing engineered OC-like organoids for prompt regeneration of large-sized bone defects.

23 November 2022 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
LGLin Gong
Lin Gong
NNNanfang Nie
Nanfang Nie
XSXilin Shen
Xilin Shen
JZJingwei Zhang
Jingwei Zhang
YLYu Li
Yu Li
XZXiaohui Zou
Xiaohui Zou
Stem cell-based tissue regeneration strategies are promising treatments for severe endometrial injuries. However, there are few appropriate seed cells for regenerating a full-thickness endometrium, which mainly consists of epithelia and stroma. Müllerian ducts in female embryonic development develop into endometrial epithelia and stroma. Hence, we first generated human pluripotent stem cells (hPSC)-derived Müllerian duct-like cells (MDLCs) using a defined and effective protocol. The MDLCs are bi-potent, can gradually differentiate into endometrial epithelial and stromal cells, and reconstitute full-thickness endometrium in vitro and in vivo. Furthermore, MDLCs showed the in situ repair capabilities of reconstructing endometrial structure and recovering pregnancy function in full-thickness endometrial injury rats, and their differentiation fate was revealed by single-cell RNA sequencing (scRNA-seq). Our study provides a strategy for hPSC differentiation into endometrial lineages and an alternative seed cell for injured endometrial regeneration.

6 May 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
JZJiayu Zhang
Jiayu Zhang
WJWei Jiang
Wei Jiang
DLDie Li
Die Li
WJWeijie Jia
Weijie Jia
DWDingfeng Wu
Dingfeng Wu
QSQiang Shu
Qiang Shu
Background: A good prognosis of congenital heart disease (CHD) depends on early diagnosis and intervention. Under the current screening conditions, a significant proportion still go undetected. Metabolomics, as a phenotype‐correlated research methodology, remains underused in the study of CHD, which could provide the possibility to screen neonatal CHD efficiently. Methods: Data for the analysis are from >22 000 neonates captured in the Network Platform for CHD from April 2020 to November 2021 in 11 cities in China. After data matching and quality control, a total of 22 674 neonates were finally included and divided into the CHD group (n=1823), nonsignificant CHD group (n=17 968), and normal group (n=2748). Demographic and clinical characteristics and tandem mass spectrometry‐based metabolic data for genetic and metabolic disease screening were gathered and compared for all groups. Machine learning models based on metabolic biomarkers were constructed to screen CHD in neonates. Results: After quality control, 22 539 neonates were ultimately included. Among them, 1823 were diagnosed with CHD, 17 968 were nonsignificant CHD, and 2748 were normal. A total of 46 distinguishing metabolic biomarkers were identified, and we found that the CHD group had significantly lower levels of 17‐hydroxyprogesterone (CHD versus nonsignificant CHD, P <0.001, log 2 fold change=−0.16; CHD versus normal, P <0.001, log 2 fold change=−0.15). We constructed CHD and ventricular septal disease screening models based on metabolic biomarkers. The best fitting model achieved an area under the receiver operating characteristic curve of 0.745 (95% CI, 0.696–0.791). Conclusions: This study reveals the unique metabolic profile of neonates with CHD. The screening model demonstrates considerable potential in early neonatal CHD screening and reflects significant value from a health economics perspective.

27 November 2024 in Research Square
Verified
Preprint
Open access
PDF file
HOHongwei Ouyang
Hongwei Ouyang
XZXianzhu Zhang
Xianzhu Zhang
WJWei Jiang
Wei Jiang
XWXinyu Wu
Xinyu Wu
CXChang Xie
Chang Xie
YHYihe Hu
Yihe Hu
Current approaches for bone repair are often focused on local delivery of growth factors that are aimed at coupled angiogenesis and osteogenesis. However, delayed revascularization and regeneration of severe bone defects are still challenging. In this study, we engineered an ossification center-like organoid (OCO) that consist of inner-core bone morphogenetic and neurotrophic spheroid generated via MSCs-loaded 3D printing, alongside the interstitially distributed outer-shell proangiogenic neurotrophic phase. Our results demonstrate that collective implantation of OCOs achieved rapid bone bridging with successive OC-like bone ossicles formation across the bone defect in a “divide-and-conquer” way. Single-cell RNA sequencing analysis unveiled a developmentally mimicking stem cell community that dominated with Krt8+ skeletal stem cells (SSCs) was uniquely recruited by the pro-regenerative in-situ organoid fusion and maturation. Particularly noteworthy is the specific expansion of Krt8+ SSCs concomitant with the simultaneous reduction of Has1+ migratory fibroblasts (MFs) 2 weeks post-OCO implantation. Furthermore, cross-species comparisons employing machine learning revealed high resemblance of relative Krt8+ SSCs/Has1+ MFs composition in bone regeneration with that in public data from developmental bone tissues. Our findings advocate an approach akin to “divide-and-conquer” utilizing engineered OC-like organoids for prompt regeneration of large-sized bone defects.